Provided by Tiger Fintech (Singapore) Pte. Ltd.

BeiGene

184.71
+0.0000
Volume:- -
Turnover:61.43M
Market Cap:19.67B
PE:-22.56
High:184.71
Open:184.71
Low:184.71
Close:184.71
Loading ...

BeiGene's Four Drugs Included in China's Medical Insurance Catalog; Shares Jump 5%

MT Newswires Live
·
29 Nov 2024

Analysts Offer Insights on Healthcare Companies: BeiGene (BGNE) and Teladoc (TDOC)

TIPRANKS
·
28 Nov 2024

Why Is BeiGene Stock Trading Higher On Wednesday?

Benzinga
·
28 Nov 2024

BeiGene Shares Up on EU Approval for Gastric, Esophageal Cancer Treatment

Dow Jones
·
27 Nov 2024

Stock Track | BeiGene Soars 5.24% as European Approval for TEVIMBRA Cancer Treatment Fuels Growth Prospects

Stock Track
·
27 Nov 2024

BeiGene's Tevimbra Gets Approval From European Commission as Treatment for Cancer Patients

MT Newswires Live
·
27 Nov 2024

BeiGene's Gastric, Esophageal Cancer Treatment Gets EU Approval

Dow Jones
·
27 Nov 2024

High Growth Tech Stocks to Watch in November 2024

Simply Wall St.
·
26 Nov 2024

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

Dow Jones
·
21 Nov 2024

China ADRs have increased to the largest share since late 2021 – GS

seekingalpha
·
21 Nov 2024

Labcorp Holdings Finance Chief Glenn Eisenberg to Retire

MT Newswires Live
·
19 Nov 2024

Labcorp gets new finance chief

seekingalpha
·
19 Nov 2024

BeiGene Announces U.S. Regulatory Filing

TIPRANKS
·
19 Nov 2024

Labcorp CFO Glenn Eisenberg Announces Plans to Retire

PR Newswire
·
19 Nov 2024

BRIEF-BeiGene Announces Settlement Of Litigation Against Generic Filer Of BRUKINSA

Reuters
·
19 Nov 2024

BeiGene Announces New Share Options and RSUs

TIPRANKS
·
19 Nov 2024

BeiGene, Ltd. (BGNE): Among 12 High Growth Large Cap Stocks to Buy Now

Insider Monkey
·
16 Nov 2024